Compare funds

The Product's investment objective is to replicate the price and performance, before fees and expenses, of the MarketVector™ Global Quantum Leaders Index (the 'Index'). In order to seek to achieve its investment objective, the Manufacturer will normally use a replication strategy by investing directly in the underlying equity securities of the Index being the equity stocks, American depositary receipts (ADRs), and global depositary receipts (GDRs) that consists of the component securities of the Index. Such equity securities must be issued by companies listed or traded on the Markets referred to in Appendix II of the Prospectus who derive 50% (25% for current components) of their revenues from or operating activity from quantum computing technology or services or have at least 5 patents related to quantum computing technology. The Product may invest more than 20% of its Net Asset Value in emerging markets. The Product may also (or alternatively) invest in financial derivative instruments (FDIs) which relate to the Index or constituents of the Index. The Product may also use futures, options (puts and calls), swaps (including equity swaps and swaps on the Index), currency forwards and non-deliverable forwards (a forward contract that does not require settlement on maturity) (NDFs). The Product may also invest in ancillary liquid assets and money market instruments which may include bank deposits, depositary receipts, certificates of deposit, fixed floating rate instruments (treasury bills), commercial paper, floating rate notes and freely transferable promissory notes. The ancillary liquid assets, money market instruments and FDI (other than permitted unlisted investments) will be listed or traded on the Markets referred to in Appendix II of the Prospectus.

The Product's investment objective is to replicate the price and performance, before fees and expenses, of the MarketVector™ Global Quantum Leaders Index (the 'Index'). In order to seek to achieve its investment objective, the Manufacturer will normally use a replication strategy by investing directly in the underlying equity securities of the Index being the equity stocks, American depositary receipts (ADRs), and global depositary receipts (GDRs) that consists of the component securities of the Index. Such equity securities must be issued by companies listed or traded on the Markets referred to in Appendix II of the Prospectus who derive 50% (25% for current components) of their revenues from or operating activity from quantum computing technology or services or have at least 5 patents related to quantum computing technology. The Product may invest more than 20% of its Net Asset Value in emerging markets. The Product may also (or alternatively) invest in financial derivative instruments (FDIs) which relate to the Index or constituents of the Index. The Product may also use futures, options (puts and calls), swaps (including equity swaps and swaps on the Index), currency forwards and non-deliverable forwards (a forward contract that does not require settlement on maturity) (NDFs). The Product may also invest in ancillary liquid assets and money market instruments which may include bank deposits, depositary receipts, certificates of deposit, fixed floating rate instruments (treasury bills), commercial paper, floating rate notes and freely transferable promissory notes. The ancillary liquid assets, money market instruments and FDI (other than permitted unlisted investments) will be listed or traded on the Markets referred to in Appendix II of the Prospectus.